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Abstract
Background: There is a substantive lack of knowledge about comorbidity in patients with frozen shoulder. The aim
of this study was to investigate whether subjective health complaints and Neuroticism would predict treatment
outcome in patients diagnosed with frozen shoulder as measured by the Shoulder Pain and Disability Index (SPADI)
and change in SPADI.
Methods: A total of 105 patients with frozen shoulder were recruited for a randomised controlled trial, where 69 were in
the intervention group and received intraarticular corticosteroid injections and 36 patients served as control group. The
SPADI was used as the outcome measure after 8 weeks, and change in SPADI from baseline to 8 weeks as a measure of
rate of recovery. To examine comorbidities, all participants completed the Subjective Health Complaints (SHC)
questionnaire with its five subscales, and the Neuroticism (N) component of the Eysenck Personality Questionnaire
Revised. Multiple regression analysis was performed with the baseline comorbidity variables that correlated significantly
with SPADI after 8 weeks, and with change in SPADI from baseline to 8 weeks, controlling for the variables intervention,
age, gender and duration of pain.
Results: In this study, patients with frozen shoulder had little comorbidity as measured with SHC and scored normally
with respect to Neuroticism. Only the Pseudoneurology subscale in SHC correlated significantly with SPADI and had
significant predictive power (p < 0.001) for the outcome at 8 weeks. The intervention group exhibited significant
statistical predictive power (p < 0.001) for the treatment outcome as measured by a change in SPADI from baseline to
8 weeks. Being female also had some predictive significance for change in SPADI (p < 0.005).
Conclusion: Psychometric parameters as measured by the Pseudoneurology subscale in SHC questionnaire did predict
the treatment outcome in frozen shoulder as measured by SPADI at 8 weeks, but not by change in SPADI from
baseline to 8 weeks. One may conclude that psychometric parameters may affect symptoms, but do not predict the
rate of recovery in frozen shoulder.
Trial registration: ClinicalTrials.gov, identifier: NCT01570985.
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Background
Frozen shoulder or capsulitis of the shoulder has a preva-
lence of 2–5% in the general population and occurs mostly
in middle age between 40 and 60 years. Women are more
commonly affected than men [1–4]. Both shoulders can
be affected simultaneously or one side becomes affected
first and then the other side a few years later in 6–17% of
patients [5–7]. One has observed a significantly adverse
impact on pain, function and quality of life in patients
with shoulder adhesive capsulitis as measured with Shoul-
der Pain and Disability Index (SPADI) and the Short Form
survey-36 (SF-36) [8]. The burden of shoulder conditions,
in terms of affecting a patient’s perception of his or her
general health, has been ranked as highly as the burden of
having any of hypertension, congestive heart failure, acute
myocardial infarction, diabetes mellitus and/or depression
[9, 10]. In a systematic review of prognostic factors for
arm, neck and shoulder complaints, the duration and de-
gree of symptoms and resulting limitation of shoulder
function were prognostic for recovery [11]. Another sys-
tematic review found that a high SPADI score [12], in
addition to greater severity and longer duration of shoul-
der pain were associated with becoming the shoulder pain
chronic [13]. Kuijpers et al. had similar findings regarding
the duration and severity of pain at the time of presenta-
tion and its association with chronic shoulder pain [14].
Comorbid factors had a significant effect on pain and dys-
function, as measured on shoulder-specific and general
health instruments, experienced by patients with adhesive
shoulder capsulitis [15]. General health may also be seen
to improve after reduction in shoulder pain and dysfunc-
tion. Functional outcome as measured by SF-36 after
arthroscopic release in refractory adhesive shoulder capsu-
litis, improved clinical and general health status for most
of the patients [16, 17].
Several questionnaires are available to measure com-
plaints among patients with chronic conditions [18]. In
Nordic countries, a validated questionnaire consisting of
29 parameters have been used to measure severity and
duration of subjective somatic and psychological com-
plaints during the previous 30 days. The SHC question-
naire is a systematic, easy and reliable way to measure
subjective health status and comorbidity [19]. It is also ar-
gued, that what may be termed as “medically unexplained
symptoms” or functional somatic syndromes [20], are bet-
ter covered under “subjective health complaints” [21].
Subjective health complaints concerning musculoskeletal
disorders, the digestive system, tiredness, dizziness, sleep
and unspecific pain etc. are common in the general popu-
lation [22, 23]. Prevalence of reported SHC was found
high in general Norwegian population, where 80% re-
ported diverse musculoskeletal complaints e.g. headache,
neck pain, back pain, pain in the arms, shoulder pain, mi-
graine and or pain in the feet on exertion. Whereas 65%
reported “pseudoneurological” complaints, including sleep
problems, tiredness, anxiety, depression, dizziness, hot
flushes and/or extra systoles, among others [23]. The SHC
questionnaire has not been used earlier for measuring
health status in patients with frozen shoulder.
Apart from the clinical characteristics, psychological fac-
tors also play a role in predicting outcome of neck and
shoulder symptoms [24]. The relationship between psycho-
social factors particularly related to work environment and
development of musculoskeletal complaints and the transi-
tion to a chronic state has been hypothesized by some au-
thors and explanatory models are suggested [25, 26].
Further, the physical and psycho-social disability in patients
with chronic pain has been shown to be associated with
patients’ pain-related beliefs [27]. Pain related fear and
avoidance is postulated to be an essential feature of chronifi-
cation of pain for at least some patients [28].
Neuroticism is a broad personality trait that reflects the
extent to which a person experiences the world as stress-
ful, threatening, and problematic. “Neuroticism has been
linked to a wide array of clinical syndromes, with particu-
larly strong associations to distress-based disorders such
as major depression and generalized anxiety disorder. The
trait has also been found to be a significant predictor of
Subjective Health Complaints” [29]. The aspect that
whether patients with frozen shoulder have comorbidity
and have neurotic symptoms that may influence response
to treatment has previously not been studied.
Aim
The aim of this study was to investigate whether Subject-
ive Health Complaints and Neuroticism would predict
treatment outcome in patients diagnosed with frozen
shoulder as measured by SPADI and change in SPADI.
Hypothesis
Comorbidity as measured with SHC and Neuroticism at
baseline can predict outcome in frozen shoulder as mea-
sured by SPADI at 8 weeks and change in SPADI from
baseline to 8 weeks.
Methods
Patients in this study were participants in a randomised
controlled trial (RCT), where 69 were in the intervention
group and received intraarticular corticosteroid injections
during a period of 8 weeks and 36 patients were in the con-
trol group [30]. Most of the patients were in stage II of fro-
zen shoulder with SPADI score around 60. The SPADI was
used as the outcome measure. We measured SPADI at
8 weeks and change in SPADI from baseline to 8 weeks.
We interpret change in SPADI as a measure of rate of re-
covery. There were statistically significant differences be-
tween those receiving intervention and the control group
after 8 weeks in the primary outcome measure. At inclusion
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and after 8 weeks, comorbidity was measured with the
SHC questionnaire and Neuroticism was measured with
the Neuroticism (N) component of the Norwegian version
of the Eysenck Personality Questionnaire- Revised short
form (EPQ-R) [31–33].
SPADI measures a combination of pain and functional
disability on a score ranging from 0 to 100, a high total
score indicating more pain and disability [12]. In the SHC
questionnaire, severity of each complaint is rated on a 4-
point scale (0 = none, 1 = some, 2 = much, 3 = severe). In
this study, we calculated the total SHC scores for 29 items
and differentiated SHC scores in five subscales. These are:
Musculoskeletal (comprising headache, neck pain, back
pain, pain in arms, shoulder pain, migraine and pain in feet
on exertion); Pseudoneurology (sleep problems, tiredness,
anxiety, depression, dizziness, hot flushes and extra sys-
toles); Gastrointestinal (stomach discomfort, heartburn,
ulcer/non-ulcer dyspepsia, stomach pain, flatulence, diar-
rhea and obstipation), Cold/Flu (flu, bad cold, cough/bron-
chitis) and Allergy (asthma, chest pain, breathing difficulty,
eczema and allergy) [19]. The EPQ-R questionnaire has
four scales: E (Extraversion vs. Introversion), N (Neuroti-
cism or Emotionality), P (Psychoticism or Tough Minded-
ness) and L (Lie scale). The short form Neuroticism (N)
questionnaire has 12 questions to be answered with yes or
no options and only this part was used in this study [31].
Statistics
Baseline variables of comorbidity and Neuroticism were ex-
plored. To have an overview of the burden of symptoms,
we performed descriptive analysis of SHC with its subscales
and Neuroticism. To select appropriate baseline scores as
predictors of outcome, we explored correlations between
SPADI at 8 weeks and change in SPADI from baseline to
8 weeks with baseline SHC total and subscale scores, and
with the Neuroticism sum score. Multiple regression ana-
lysis was performed with the items that correlated signifi-
cantly with SPADI at 8 weeks and change in SPADI from
baseline to 8 weeks as predictors, controlling for interven-
tion, age, gender and duration of shoulder pain. We chose
a backward elimination method for multiple regression
analysis, and removed non-significant predictors one by
one. Both initial and final models are reported.
Results
Baseline characteristics of patients and SPADI are displayed
in Tables 1 and 2. There were no noteworthy differences in
the demography between the intervention and control
groups at baseline except for a higher percentage of patients
with trauma in the intervention group. The baseline SPADI
was similar in the two groups (Table 2). Descriptive scores
for SHC and for Neuroticism at baseline and 8 weeks pre-
sented in Table 3, show relatively low prevalence of health
complaints. The preliminary correlation analysis returned
significant Pearson’s correlation coefficients for SPADI at
8 weeks versus total SHC score at baseline, the Pseudo-
neurology subscale in SHC at baseline (p = 0.009), as well
as group allocation (p < 0.001) (Table 4). None of the other
SHC subscales at baseline returned significant correlation
coefficients. There was a significant correlation between fe-
male gender and SPADI at baseline. When we removed the
Pseudoneurology subscale from the total SHC score at
baseline, the remaining total SHC score became insignifi-
cant. This showed that the significant correlation coefficient
related to the total SHC baseline score was due to inclusion
of the Pseudoneurology subscale. Therefore, only the Pseu-
doneurology subscale and not the total SHC baseline score
was kept as predictor in the multiple regression analysis.
No correlation was found between baseline Neuroticism
and the outcome measure after 8 weeks. Correlation ana-
lysis with change in SPADI from baseline to 8 weeks
showed statistically significant correlation to group alloca-
tion and female gender (Table 4).
Table 1 Baseline characteristics of patients diagnosed with
frozen shoulder
Characteristics Intervention group
Number and % within
group n = 69
Control group
Number and % within
group n = 36
Mean age (years) 53 (8.7) 54 (6.9)
Female 42 (60%) 19 (53%)
Duration in months:
Median (range)
7.2 (2.0–37.0) 6.0 (3.0–24.0)
Affected right shoulder 30 (43%) 15 (42%)
Previous frozen shoulder 10 (14%) 4 (11%)
Concurrent neck pain 31 (44%) 16 (44%)
Trauma to shoulder 13 (19%) 3 (8%)
Previous operation on
shoulder
6 (9%) 1 (3%)
Dominant right side 64 (91%) 34 (94%)
Previous shoulder
treatment
37 (53%) 13 (36%)
Analgesics 33 (47%) 11 (31%)
Participants on sick
leave
14 (20%) 15 (42%)
Smokers 6 (18%) 12 (33%)
Table 2 SPADI at baseline and 8 weeks, and change in SPADI








Baseline 62.3 (16.4) 61.4 (19.07)
8 weeks 22.2 (20.3) 43.5 (23.8)
Change from baseline to
8 weeks
40.2 (19.0) 17.8 (15.0)
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Multiple regression analysis with SPADI at 8 weeks as
the dependent variable, controlling for age and gender,
revealed a statistically significant predictive value for
Pseudoneurology in SHC at baseline (p < 0.001) and
group allocation (p < 0.001) (Table 5). Shoulder pain
duration was also registered but did not show any statis-
tically significant predictive value.
Being allocated to the intervention or control group
exhibited statistical significant predictive value. This was
also the case for change in SPADI from baseline to
8 weeks (p < 0.001). Baseline SHC scores did not have
significant predictive value at 8 weeks for a change in
SPADI. Shoulder pain duration showed a statistically sig-
nificant predictive value for change in SPADI from base-
line to 8 weeks (p < 0.01).
Discussion
In this study, we found that patients with frozen shoulder
had little comorbidity as measured with SHC and they
scored normally on the Neuroticism questionnaire. We
found that both the SHC Pseudoneurology subscale and
group allocation predicted pain and function as measured
by SPADI at 8 weeks. However, when looking at factors
predicting change in SPADI from baseline to 8 weeks,
shoulder pain duration and group allocation predicted
better outcome, while SHC as a whole and each subscale
lost its predictive power.
Most of the participants were in stage II of frozen
shoulder [30] with relatively high baseline SPADI score
(Table 2). The mean duration of frozen shoulder at the
time of inclusion in the study was 6 months (Table 1).
Some patients go through a very painful phase and de-
layed diagnosis resulting in frustration, anxiety and de-
pression. Jones et al. observed in their study that lack of
diagnosis or misdiagnosis led to diverse consequences
among the participants; for example, anxiety, denial and
delays in definitive diagnosis and referral [34]. In pa-
tients with cervical radiculopathy, variables regarding
present neck pain intensity, fear avoidance and anxiety
were most significant in dimensions underlying pain and
disability, personal factors and health status [35]. One of
the major complaints in frozen shoulder in late stage I
and stage II is pain which in some cases can be very se-
vere [36], resulting in very disturbed sleep and tiredness.
Perceived disability in patients with chronic shoulder
pain has been found to be strongly influenced by





Baseline 8 weeks Baseline 8 weeks
SHC - Total score 29 items
(score 0–87)
15.34 (8.16) 11.33 (8.04) 12.22 (6.66) 11.08 (7.98)
Musculoskeletal (8 items)
(score 0–24)
8.11 (4.06) 5.62 (3.87) 7.44 (3.45) 6.50 (3.57)
Pseudoneurology (7 items)
(score 0–21)
4.17 (3.03) 3.23 (2.98) 3.11 (2.67) 2.86 (3.07)
Gastrointestinal (7 items)
(score 0–21)
1.70 (2.30) 1.35 (1.92) 0.92 (1.44) 0.94 (1.66)
Flu (2 items)
(score 0–9)
0.57 (1.11) 0.67 (1.07) 0.56 (1.27) 0.53 (1.08)
Allergy (5 items)
(score 0–15)
0.76 (1.36) 0.48 (0.95) 0.25 (0.55) 0.36 (1.05)
Neuroticism
(score 0–12)
2.42 (2.14) 1.57 (2.05) 2.06 (2.28) 1.50 (1.80)
Table 4 Pearson’s correlationsa between independent variables and SPADI at 8 weeks and change in SPADI from baseline to
8 weeks
Correlated independent variables SPADI at 8 weeks Change in SPADI
(baseline to 8 weeks)
Pearson’s r p-value Pearson’s r p-value
SHC Pseudoneurology baseline 0.26* 0.009 0.11 0.287
Gender (male = 0; female = 1) 0.08 0.429 0.26* 0.007
Group allocation (control = 0; intervention = 1) − 0.45* < 0.001 − 0.43* < 0.001
Shoulder pain duration − 0.16 0.108 0.28* 0.004
*p < 0.05
aOnly variables with significant correlations are listed in the table
Sharma et al. BMC Musculoskeletal Disorders  (2017) 18:380 Page 4 of 7
depressive symptoms [37]. In our study, 44% of patients
in both groups also had neck pain, which may have con-
tributed to elevated self-experience of pain or disability
(Table 1). It is possible, that after receiving information
at the time of inclusion in the study regarding frozen
shoulder and its natural course patient’s anxiety and de-
pressive symptoms were reduced. The Pseudoneurology
subscale was no longer significantly predictive with re-
gard to change in SPADI from baseline to 8 weeks.
In this study, the follow up was limited to 8 weeks and
this may affect external validity. A further follow up at 6
or 12 months would have been appropriate to predict
long-term outcome. This is a limitation of this study.
Since we lack reference values for SHC and Neuroti-
cism, we cannot compare our findings with the general
population. This is also a limitation of the study.
In our study, Neuroticism did not have any significance in
predicting the outcome of frozen shoulder. Others have
found that personality factors may modulate presentation of
pain and symptoms and influence a broad range of health
outcomes and mechanisms [20, 38]. Rozencwaig et al. have
demonstrated that the number of medical conditions has a
quantitative effect on shoulder function. The parameters for
general health perception and vitality in the SF-36 question-
naire has previously been found to have a strong negative
correlation with the increasing comorbidity in patients with
gleno-humeral degenerative joint disease [39].
Belonging to the intervention group had significant
predictive value (p < 0.001) for both SPADI at 8 weeks
and change in SPADI from baseline to 8 weeks. Con-
trary to what we had expected, SHC total score, SHC
subscales and Neuroticism had no predictive value for
change in SPADI from baseline to 8 weeks. We ex-
pected the Musculoskeletal subscale to have a predict-
ive power because this subscale contains parameters
regarding neck pain, back pain, pain in arms,
shoulder pain and pain in feet, which are relevant to
this study. We do not have any good explanation for
this lack of predictive influence. Absence of predictive
power for Neuroticism is in accordance with findings
in other studies. Ring et al. found that self-reported
upper extremity-specific health status correlated with
the Disabilities of the Arm, Shoulder and Hand
(DASH) questionnaire, but not with Neuroticism, as
measured by the EPQ-R [40]. Factorial analysis of
subjectively felt health complaints by Ursin et al. re-
vealed that factors involving neck, back, arm and
shoulder pain and migraine, did not relate to anxiety
and depression [41]. Psychological factors explained
only a moderate amount of variance of muscle pain,
when the population was looked at as a whole, in
their study [41]. This is similar to our findings, i.e.
the Musculoskeletal subscale did not show predictive
power for SPADI. In general, psychological comorbid-
ity has been found to enhance self-experience of suf-
fering due to pain and dysfunction. Bagheri et al.
reported more suffering due to depression and anxiety
than that from a reduced range of motion in patients
with frozen shoulder [42]. Further, physical and psy-
chosocial disability in patients with chronic pain have
been shown to be associated with patients’ pain-
related beliefs [27]. Patients with psychological disor-
ders have been found to have more self-reported pain
and functional disability in activities of daily life, indi-
cating correlation with frozen shoulder and psycho-
logical conditions [43]. However, the Musculoskeletal
subscale did not predict the outcome in our study
even though it has components of pain parameters.
There is a possibility that the SHC and Neuroticism
questionnaires are not able to measure psychometric
parameters when these are not sufficiently accentu-
ated or are dominating the clinical picture. However,
Table 5 Multiple regression models with backward elimination for participants (n = 105, control and intervention groups) with the
Shoulder Pain and Disability Index (SPADI) at 8 weeks and change in SPADI from baseline to 8 weeks as dependent variables
Initial model Final model
B p-value R2 B p-value R2
SPADI at 8 weeks 0.30 0.29
SHC Pseudoneurology baseline 2.4 0.001 2.6 < 0.001
Gender (male = 0; female = 1) 0.78 0.85
Age − 0.36 0.15
Group allocation (control = 0; intervention = 1) − 25.1 < 0.001 − 24.8 < 0.001
Change in SPADI from baseline to 8 weeks 0.36 0.36
SHC Pseudoneurology baseline 0.19 0.77
Gender (male = 0; female = 1) 11.78 0.002 11.99 0.002
Age 0.48 0.04 0.47 0.04
Group allocation (control = 0; intervention = 1) 19.50 < 0.001 19.73 < 0.001
Shoulder pain duration 0.93 0.91 0.013
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frozen shoulder may be a very distinct physical and
clinical entity, without associated psychological as-
pects. When patients are informed of the diagnosis,
its natural history and possible outcome after inter-
vention, the condition is no longer dramatic and they
cope well with it. According to available literature,
psychometric parameters can in some way affect the
outcome [15, 24–26], but it was not obvious or con-
sistent in our study.
Conclusion
Psychometric parameters as measured by the Pseudo-
neurology subscale in SHC questionnaire did predict the
treatment outcome in frozen shoulder as measured by
SPADI at 8 weeks, but not by change in SPADI from
baseline to 8 weeks. One may conclude that psychomet-
ric parameters may affect symptoms, but do not predict
the rate of recovery in frozen shoulder.
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